Telomeric alterations in the default mode network during the progression of Alzheimer's disease: selective vulnerability of the precuneus
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Aims: Although telomere length (TL) and telomere maintenance proteins (shelterins) are markers of cellular senescence and peripheral blood biomarkers of Alzheimer's disease (AD), little information is available on telomeric alterations during the prodromal stage (MCI) of AD. We investigated TL in the default mode network (DMN), which underlies episodic memory deficits in AD, as well as shelterin protein and mRNA levels in the precuneus (PreC). Methods: Telomere length was evaluated in DMN hubs and visual cortex using quantitative PCR (qPCR). In the PreC, western blotting and NanoString nCounter expression analyses evaluated shelterin protein and mRNA levels, respectively, in cases with an antemortem clinical diagnosis of no cognitive impairment (NCI), MCI and AD. Results: TL was significantly reduced in the PreC in MCI and AD compared to NCI, but stable in frontal, inferior temporal, posterior cingulate and visual cortex. PreC TL correlated significantly with performance on cognitive tests. NCI cases with high vs low Braak scores displayed significantly shorter TL in posterior cingulate and frontal cortex, which correlated significantly with neuritic and diffuse amyloid‐β plaque counts. Shelterin protein levels (TIN2, TRF1, TRF2 and POT1) declined in MCI and AD compared to NCI. The PreC displayed stable expression of shelterins TERF1, TERF2, POT1, RAP1 and TPP1, while TINF2 mRNA significantly increased in AD compared to NCI. Conclusions: These findings indicate a selective vulnerability to telomere attrition within different nodes of the DMN in prodromal AD and in aged NCI individuals with high Braak scores highlighting a putative role in the pathogenesis of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Population-based studies have shown that telomere shortening was evident in patients with mild cognitive impairment compared to healthy control [8].”
From Integrated multi-omics analysis revealed the molecular networks and potential targets of cellular senescence in Alzheimer’s disease (2025) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Cognitive reserve in ageing and Alzheimer's disease
Stern, Y. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70191-6 · Cited by 3,557
Montine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
Cheignon, C., Tomas, M., Bonnefont-Rousselot, D., Faller, P., Hureau, C., & Collin, F. (2018) · Redox Biology · doi:10.1016/j.redox.2017.10.014 · Cited by 2,185
Neuropathology of older persons without cognitive impairment from two community-based studies
Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000219668.47116.e6 · Cited by 1,336
[ 11 C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
Mintun, M. A., LaRossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., Klunk, W. E., Mathis, C. A., DeKosky, S. T., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000228230.26044.a4 · Cited by 1,036
Sperling, R. A., LaViolette, P. S., O'Keefe, K., O'Brien, J., Rentz, D. M., Pihlajamaki, M., Marshall, G., Hyman, B. T., Selkoe, D. J., Hedden, T., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.07.003 · Cited by 1,027
Individual differences in rates of change in cognitive abilities of older persons.
Wilson, R. S., Beckett, L. A., Barnes, L. L., Schneider, J. A., Bach, J., Evans, D. A., & Bennett, D. A. (2002) · Psychology and Aging · doi:10.1037/0882-7974.17.2.179 · Cited by 842
Rombouts, S. A. R. B., Barkhof, F., Goekoop, R., Stam, C. J., & Scheltens, P. (2005) · Human Brain Mapping · doi:10.1002/hbm.20160 · Cited by 734
Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship
Nelson, P. T., Braak, H., & Markesbery, W. R. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181919a48 · Cited by 643
Telomeres shorten at equivalent rates in somatic tissues of adults
Daniali, L., Benetos, A., Susser, E., Kark, J. D., Labat, C., Kimura, M., Desai, K. K., Granick, M., & Aviv, A. (2013) · Nature Communications · doi:10.1038/ncomms2602 · Cited by 601
Sheline, Y. I., Raichle, M. E., Snyder, A. Z., Morris, J. C., Head, D., Wang, S., & Mintun, M. A. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.024 · Cited by 597
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions
Bennett, D. A., Schneider, J. A., Bienias, J. L., Evans, D. A., & Wilson, R. S. (2005) · Neurology · doi:10.1212/01.wnl.0000152982.47274.9e · Cited by 537
Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease
Lovell, M. A., & Markesbery, W. R. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm821 · Cited by 515
Cell cycle regulation in the postmitotic neuron: oxymoron or new biology?
Herrup, K., & Yang, Y. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2124 · Cited by 507
Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer’s disease
Yang, Y., Mufson, E. J., & Herrup, K. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02557.2003 · Cited by 483
Self-citationSite‐specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening
Oikawa, S., & Kawanishi, S. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00748-6 · Cited by 435
Ribosome Dysfunction Is an Early Event in Alzheimer's Disease
Ding, Q., Markesbery, W. R., Chen, Q., Li, F., & Keller, J. N. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3040-05.2005 · Cited by 433
The role of mitochondrial ROS in the aging brain
Stefanatos, R., & Sanz, A. (2018) · FEBS Letters · doi:10.1002/1873-3468.12902 · Cited by 358
de Jesus, B. B., Schneeberger, K., Vera, E., Tejera, A., Harley, C. B., & Blasco, M. A. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00700.x · Cited by 348
Mosconi, L. (2013) · Clinical and Translational Imaging · doi:10.1007/s40336-013-0026-y · Cited by 328
Oxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2
Opresko, P. L. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki273 · Cited by 289
Newell, K. L., Hyman, B. T., Growdon, J. H., & Hedley-Whyte, E. T. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199911000-00004 · Cited by 289
Altered Machinery of Protein Synthesis in Alzheimer's: From the Nucleolus to the Ribosome
Hernández‐Ortega, K., Garcia‐Esparcia, P., Gil, L., Lucas, J. J., & Ferrer, I. (2016) · Brain Pathology · doi:10.1111/bpa.12335 · Cited by 245
Meta-analysis of Telomere Length in Alzheimer’s Disease
Forero, D. A., González-Giraldo, Y., López-Quintero, C., Castro-Vega, L. J., Barreto, G. E., & Perry, G. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw053 · Cited by 229
Oxidant/Antioxidant Imbalance in Alzheimer’s Disease: Therapeutic and Diagnostic Prospects
Wojsiat, J., Zoltowska, K. M., Laskowska-Kaszub, K., & Wojda, U. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6435861 · Cited by 221
Telomere shortening in human diseases
Kong, C. M., Lee, X. W., & Wang, X. (2013) · The FEBS Journal · doi:10.1111/febs.12326 · Cited by 194
Telomere shortening in neurological disorders: an abundance of unanswered questions
Eitan, E., Hutchison, E. R., & Mattson, M. P. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.02.010 · Cited by 158
The Role of Telomerase Protein TERT in Alzheimer's Disease and in Tau-Related Pathology In Vitro
Spilsbury, A., Miwa, S., Attems, J., & Saretzki, G. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2925-14.2015 · Cited by 140
From cellular senescence to Alzheimer’s disease: The role of telomere shortening
Boccardi, V., Pelini, L., Ercolani, S., Ruggiero, C., & Mecocci, P. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.04.003 · Cited by 121
Telomere Length Shortening and Alzheimer Disease—A Mendelian Randomization Study
Zhan, Y., Song, C., Karlsson, R., Tillander, A., Reynolds, C. A., Pedersen, N. L., & Hägg, S. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1513 · Cited by 111
Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model
Garcia-Alloza, M., Dodwell, S. A., Meyer-Luehmann, M., Hyman, B. T., & Bacskai, B. J. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000240468.12543.af · Cited by 99
Nelson, P. T., Abner, E. L., Scheff, S. W., Schmitt, F. A., Kryscio, R. J., Jicha, G. A., Smith, C. D., Patel, E., & Markesbery, W. R. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2008.11.006 · Cited by 70
Research works printed but not linked: 82
- 10.1212/WNL.0b013e3182231419 · DOI · Paper page
- 10.1016/j.biopsych.2013.12.016 · DOI · Paper page
- 10.1002/cne.24929 · DOI
- 10.1111/bpa.12331 · DOI · Paper page
- 10.1016/j.bbr.2008.08.012 · DOI · Paper page
- 10.1016/j.neulet.2008.04.021 · DOI · Paper page
- 10.1155/2015/583931 · DOI · Paper page
- 10.3389/fnins.2016.00582 · DOI
- 10.1016/j.neurobiolaging.2017.01.022 · DOI
- 10.1159/000492945 · DOI
- 10.3233/JAD-122353 · DOI · Paper page
- Martinez‐Gonzalez K, 2019, Telomere length and oxidative stress in the progression of Alzheimer’s disease, bioRxiv
- 10.1016/j.neuint.2013.02.013 · DOI · Paper page
- 10.1101/cshperspect.a012666 · DOI
- 10.1002/ajmg.b.32575 · DOI
- 10.1016/j.trci.2019.11.003 · DOI · Paper page
- Jenkins E, 2015, Telomere longitudinal shortening as a biomarker for dementia status of adults with down syndrome, AM J Med Gen, 171, 169, 10.1002/ajmg.b.32389 · DOI
- 10.1093/brain/awl004 · DOI · Paper page
- 10.1056/NEJMra0903373 · DOI · Paper page
- 10.1128/MCB.00541-16 · DOI
- 10.1080/19491034.2015.1048407 · DOI · Paper page
- 10.1101/gad.1346005 · DOI · Paper page
- 10.4161/nucl.2.2.15135 · DOI · Paper page
- 10.1007/s40520-013-0021-1 · DOI
- 10.1038/345458a0 · DOI · Paper page
- 10.1016/j.exger.2014.06.018 · DOI
- 10.1016/j.jalz.2006.03.001 · DOI · Paper page
- 10.1016/j.mad.2007.12.004 · DOI · Paper page
- 10.3233/JAD-142808 · DOI · Paper page
- 10.1002/ana.20894 · DOI · Paper page
- 10.1080/01616412.2019.1580456 · DOI
- 10.1016/j.mad.2014.10.002 · DOI
- 10.3233/JAD-190010 · DOI
- 10.1038/labinvest.3780184 · DOI · Paper page
- 10.1016/j.jalz.2009.05.666 · DOI · Paper page
- 10.1016/j.exger.2011.12.005 · DOI
- 10.1016/j.exger.2011.12.005 · DOI
- 10.2174/1874609808666150122153151 · DOI · Paper page
- 10.1093/nar/gkn1027 · DOI · Paper page
- 10.1093/nar/30.10.e47 · DOI · Paper page
- 10.1006/exnr.1999.7086 · DOI · Paper page
- 10.3233/JAD-141518 · DOI · Paper page
- Mai J, 2015, Atlas of the Human Brain
- 10.1097/NEN.0b013e318272caab · DOI · Paper page
- 10.1016/j.ajpath.2011.10.027 · DOI · Paper page
- 10.1212/WNL.59.2.198 · DOI · Paper page
- 10.2174/156720512801322591 · DOI · Paper page
- 10.1017/S1041610297004985 · DOI
- 10.1007/s00401-016-1537-1 · DOI · Paper page
- 10.1002/ana.20233 · DOI · Paper page
- 10.1214/aos/1013699998 · DOI · Paper page
- 10.1038/nsmb.3092 · DOI · Paper page
- 10.1097/NEN.0b013e31825018f7 · DOI · Paper page
- 10.1016/j.neurobiolaging.2015.10.012 · DOI · Paper page
- 10.1016/j.bbr.2016.05.030 · DOI · Paper page
- 10.1523/JNEUROSCI.0379-07.2007 · DOI · Paper page
- 10.1111/j.1474-9726.2012.00826.x · DOI · Paper page
- 10.1111/j.1365-2990.2007.00908.x · DOI
- 10.1016/j.freeradbiomed.2007.10.001 · DOI · Paper page
- 10.1016/j.neuroscience.2006.11.052 · DOI
- Wang X, 2010, Selective neuronal vulnerability to oxidative stress in the brain, Front Aging Neurosci, 2, 12
- 10.1016/S0197-4580(02)00043-X · DOI · Paper page
- 10.1074/jbc.M409047200 · DOI · Paper page
- 10.1038/nature07433 · DOI · Paper page
- 10.1038/nature08196 · DOI · Paper page
- 10.1016/S0092-8674(00)80932-0 · DOI · Paper page
- 10.1038/ncomms6467 · DOI · Paper page
- 10.1016/j.diff.2018.06.001 · DOI
- 10.1093/brain/awr066 · DOI · Paper page
- 10.1038/s41467-017-01313-w · DOI · Paper page
- Garcia‐Esparcia P, 2017, Altered mechanisms of protein synthesis in frontal cortex in Alzheimer disease and a mouse model, Am J Neurodegener Dis, 6, 15
- 10.1101/gad.245662.114 · DOI · Paper page
- 10.1371/journal.pone.0053349 · DOI · Paper page
- 10.1073/pnas.1516604113 · DOI · Paper page
- 10.3389/fnmol.2019.00024 · DOI
- 10.1016/j.neuroimage.2009.05.080 · DOI
- Trimble M, Handbook of Episodic Memory, 363
- 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X · doi:10.1002/1531-8249(199903)45:3<358::aid-ana12>3.0.co;2-x
- 10.1016/j.neurobiolaging.2016.03.003 · DOI
- 10.1001/archneur.1995.00540360028012 · DOI · Paper page
- 10.1007/s00401-015-1407-2 · DOI · Paper page
- 10.1089/rej.2010.1085 · DOI · Paper page
Cited by
Cellular senescence at the crossroads of inflammation and Alzheimer's disease
Guerrero, A., De Strooper, B., & Arancibia-Cárcamo, I. L. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.06.007 · Cited by 236
Diverse roles of ceramide in the progression and pathogenesis of Alzheimer's disease
Chowdhury, M. R., Jin, H. K., & Bae, J.-S. (2022) · Biomedicines · doi:10.3390/biomedicines10081956 · Cited by 47
Xu, Y., Liu, S., Zhou, Z., Qin, H., Zhang, Y., Zhang, G., Ma, H., Han, X., Liu, H., & Liu, Z. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddae189 · Cited by 6
Metadata
- Authors
- Mahady, L. J., He, B., Malek‐Ahmadi, M., & Mufson, E. J.
- Affiliations
- Department of Neurobiology Barrow Neurological Institute Phoenix AZ USA
- Banner Alzheimer’s Institute Phoenix AZ USA
- Venue
- Neuropathology and Applied Neurobiology
- Publisher
- Wiley
- Published
- 2020-12-05
- Volume
- 47
- Issue
- 3
- Pages
- 428-440
- ISSN
- 0305-1846
- 1365-2990
- Cited by
- 20
- References
- 33
- Language
- en
- Funders
- BrightFocus Foundation
- Barrow Neurological Foundation
- National Institute on Aging (P30AG010161, P30AG019610, PO1AG014449, RO1AG042146, RO1AG043375)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.